COMP <GO>
CLPT vs EMBC // 10Y YIELD & FRED MACRO BETA
ClearPoint Neuro Inc. (NASDAQ) VS. Embecta Corp. (NASDAQ) • 15-METRIC TALLY: CLPT 1
— EMBC 8
■ METRIC PARITY
LAST: $10.69 (+1.23%) • MKT CAP: $342.7M
macro-sensitivity
—
LAST: $6.56 (+1.55%) • MKT CAP: $371.7M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLPT VS. EMBC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLPT | EMBC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 61.40% | 62.60% | -1.20 | EMBC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 35.50% | -70.50 | EMBC | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 6.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.13% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | 22.40% | -82.40 | EMBC | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 8.80% | -68.80 | EMBC | /net-margins <GO> |
| Revenue Growth (YoY) | 17.80% | -3.80% | +21.60 | CLPT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 9.42% | -9.42 | EMBC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | EMBC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.1 | 58.3 | -9.20 | EMBC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 3.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $342.7M | $371.7M | -$29.0M | EMBC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLPT REV | EMBC REV | CLPT GROSS % | EMBC GROSS % | CLPT FCF | EMBC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $37.0M | $1.08B | 61.4% | 62.6% | -$24.4M | $182.4M |
| FY 2024 | $31.4M | $1.12B | 60.9% | 65.5% | -$9.2M | $19.9M |
| FY 2023 | $24.0M | $1.12B | — | — | -$13.7M | $67.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLPT // BETA —
EMBC // BETA —